What is LLY's current stock price?

As of now, LLY is trading at $1031.13, with a daily change of -4.06%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

LLY Stock Analysis & IQ Rating | Eli Lilly and

LLY LLY Badge

Eli Lilly and

$1031.13

-$42.68 | -4.06%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$1133.95

MKT CAP

$973.75B

52W Low

$623.78

VOL

$3.40M

P/E Ratio

50.45

AVG VOL

$2.96M

RSI

44.53

TREND

Sideways

LLY Stock IQ

Login to see Eli Lilly and (LLY) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

LLY Target Price

Login to display

Strengths

LLY Rewards

Earnings are forecast to grow

LLY Rewards

Upgraded on attractively valued

LLY Rewards

Trading below its fair value

LLY Rewards

Investors confidence is positive

LLY Price Performance

$1041.79 (-1.02%)

$808.96 (+27.46%)

$711.68 (+44.89%)

$811.08 (+27.13%)

1year

6month

3month

1month

LLY Risk Level

LLY has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

LLY Analysts Opinion

LLY overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

LLY Analysts Opinion

LLY Analysts opinion is positive and also has improved from the past 3 months

LLY Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

88%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

61%

100%

LLY Street Sentiment

LLY Street Sentiment is extremely bullish and have positive views on the near-term outlook

LLY Performance Sentiment

Sentiments overview associated with LLY events and the stock performance.

88%

10%

Positive

Negative

74 out of 84
events present

8 out of 84
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$1073.29

Resistance
Price

$1002.65

Current Price Range

$1109.94

Show methods +

Linked to LLY

IQ

Close Price

Change

NVO

4.05

57.02

-3.21%

PFE

4.25

25.87

+1.11%

SNY

3.94

47.38

-1.01%

NVS

4.12

143.28

-2.01%

MRK

4.24

110.93

+0.32%

Recently Viewed

Close Price

Change

LLY

Eli Lilly and

1031.13

-4.06%

KRNT

Kornit Digital Ltd.

14.55

0.00%

FTV

Fortive

55.69

-0.45%

UBER

Uber Technologies

84.36

-0.52%

IMCC

IM Cannabis Corp.

1.34

-5.63%

LLY Latest Analysis +

Where is Eli Lilly and Company (LLY) Headed According to Analysts?. Eli Lilly and Company (NYSE:LLY) is one of the best long term growth stocks to buy according to hedge funds. On January 9 Jefferies reaffirmed a Buy rating on Eli Lilly and Company (NYSE:LLY) and set a price target of $1300.00. The rating update came after Eli Lilly and Company (NYSE:LLY) announced on January 8 [….]

Today

$1031.13 | -4.06%

Potential

Rating

How Will Mounjaro and Zepbound Sales Aid LLYs Upcoming Q4 Results?. Eli Lillys Q4 revenues are expected to reflect strong Mounjaro and Zepbound demand as supply gains and global uptake offset pricing pressure.

Today

$1031.13 | -4.06%

Activity

Eli Lilly shares dip as FDA delays decision on weight-loss pill.

Today

$1031.13 | -4.06%

Momentum

Heres Why Eli Lilly (LLY) is a Strong Momentum Stock. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.

Wed Jan 14, 2026

$1073.29 | -0.36%

Momentum

Why Eli Lilly Stock Gained 39.2% In 2025. Key PointsEli Lillys weight-loss drugs are experiencing rapid growth.

Wed Jan 14, 2026

$1073.29 | -0.36%

Potential

Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff. Issued on behalf of Oncolytics Biotech Inc.Equity-Insider.com News Commentary – The precision oncology market is hitting a massive growth spurt projected to rocket from [1]. This gold rush is accelerating as Big Pharma giants scramble to survive a looming [2]. This high-stakes hunt for registration-ready assets is driving the 2026 investment case for Oncolytics Biotech Inc. (NASDAQ:) Nurix Therapeutics (NASDAQ:)

Wed Jan 14, 2026

$1073.29 | -0.36%

Activity

Behind the Scenes of Eli Lilly and Cos Latest Options Trends. Investors with a lot of money to spend have taken a bearish stance on ).And retail traders should know.We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.Whether these are institutions or just wealthy individuals we don'.t know. But when something this big happens with LLY it often means somebody knows something is about to happen.So how do we know what these invest

Wed Jan 14, 2026

$1073.29 | -0.36%

Activity

Momentum

Is It Time to Dump Your Shares of Eli Lilly?. Key PointsEli Lilly leads in the GLP-1 drug space with its shot-based offerings Mounjaro and Zepbound.

Wed Jan 14, 2026

$1073.29 | -0.36%

Momentum

Jim Cramer Calls Nvidia Eli Lilly Partnership Monumental Effort To Speed Up Critical Drug Creation. NVDA) and ) calling their deep collaboration a “.monumental effort”. to revolutionize drug development that Wall Street is foolishly dismissing as a “.gigantic sideshow.”.While the broader market remains fixated on daily earnings fluctuations and inflation data Cramer urged investors to focus on the structural shift happening in San Francisco.Nvidia and Eli Lilly have cemented

Wed Jan 14, 2026

$1073.29 | -0.36%

Activity

Can Novo Nordisk Unseat Eli Lilly as the Weight Loss Drug Leader in 2026?. Key PointsNovo Nordisk launched an oral version of its best-selling weight management medicine.

Tue Jan 13, 2026

$1077.19 | -0.33%

Activity

FAQ About LLY Stock Insights

What is LLY current stock price?

What are LLY stock strengths?

What is LLY Risk Level?

What is LLY market cap and volume?

What is LLY current Stock IQ?

Should I buy LLY stock right now?

Is LLY a Strong Buy right now?

What does a 'Strong Buy' rating mean for LLY?

What does a 'Strong Sell' rating mean for LLY?

What factors influence LLY's Stock IQ?

Explore our LLY Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored LLY Stock Strategies
Effective Risk Management

FIND US ON

Receive our LLY Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

LLY LLY Badge

Eli Lilly and

Set Alerts

Current Price

$1031.13

-$42.68 | -4.06%

52W High

$1133.95

MKT CAP

$973.75B

52W Low

$623.78

VOL

$3.40M

P/E Ratio

50.45

AVG VOL

$2.96M

RSI

44.53

TREND

Sideways

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

LLY Stock IQ

Login to unlock Eli Lilly and (LLY) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Target Price

Login to display

Stock Insights

Strengths

LLY Rewards

Earnings are forecast to grow

LLY Rewards

Upgraded on attractively valued

LLY Rewards

Trading below its fair value

LLY Rewards

Investors confidence is positive

Linked to LLY

Symbol

IQ

Close

Change

NVO

4.05

57.02

-3.21%

PFE

4.25

25.87

+1.11%

SNY

3.94

47.38

-1.01%

NVS

4.12

143.28

-2.01%

MRK

4.24

110.93

+0.32%

LLY Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

88%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

61%

100%

LLY Street Sentiment

LLY Street Sentiment is extremely bullish and have positive views on the near-term outlook

LLY Risk Level

LLY has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

LLY Performance Sentiment

Sentiments overview associated with LLY events and the stock performance.

88%

10%

Positive

Negative

74 out of 84
events present

8 out of 84
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$1073.29

Resistance
Price

$1002.65

Current Price Range

$1109.94

Show methods +

LLY Latest Analysis

Where is Eli Lilly and Company (LLY) Headed According to Analysts?. Eli Lilly and Company (NYSE:LLY) is one of the best long term growth stocks to buy according to hedge funds. On January 9 Jefferies reaffirmed a Buy rating on Eli Lilly and Company (NYSE:LLY) and set a price target of $1300.00. The rating update came after Eli Lilly and Company (NYSE:LLY) announced on January 8 [….]

Today

$1031.13 | -4.06%

Potential

Rating

How Will Mounjaro and Zepbound Sales Aid LLYs Upcoming Q4 Results?. Eli Lillys Q4 revenues are expected to reflect strong Mounjaro and Zepbound demand as supply gains and global uptake offset pricing pressure.

Today

$1031.13 | -4.06%

Activity

Eli Lilly shares dip as FDA delays decision on weight-loss pill.

Today

$1031.13 | -4.06%

Momentum

Heres Why Eli Lilly (LLY) is a Strong Momentum Stock. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.

Wed Jan 14, 2026

$1073.29 | -0.36%

Momentum

Why Eli Lilly Stock Gained 39.2% In 2025. Key PointsEli Lillys weight-loss drugs are experiencing rapid growth.

Wed Jan 14, 2026

$1073.29 | -0.36%

Potential

Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff. Issued on behalf of Oncolytics Biotech Inc.Equity-Insider.com News Commentary – The precision oncology market is hitting a massive growth spurt projected to rocket from [1]. This gold rush is accelerating as Big Pharma giants scramble to survive a looming [2]. This high-stakes hunt for registration-ready assets is driving the 2026 investment case for Oncolytics Biotech Inc. (NASDAQ:) Nurix Therapeutics (NASDAQ:)

Wed Jan 14, 2026

$1073.29 | -0.36%

Activity

Behind the Scenes of Eli Lilly and Cos Latest Options Trends. Investors with a lot of money to spend have taken a bearish stance on ).And retail traders should know.We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.Whether these are institutions or just wealthy individuals we don'.t know. But when something this big happens with LLY it often means somebody knows something is about to happen.So how do we know what these invest

Wed Jan 14, 2026

$1073.29 | -0.36%

Activity

Momentum

Is It Time to Dump Your Shares of Eli Lilly?. Key PointsEli Lilly leads in the GLP-1 drug space with its shot-based offerings Mounjaro and Zepbound.

Wed Jan 14, 2026

$1073.29 | -0.36%

Momentum

Jim Cramer Calls Nvidia Eli Lilly Partnership Monumental Effort To Speed Up Critical Drug Creation. NVDA) and ) calling their deep collaboration a “.monumental effort”. to revolutionize drug development that Wall Street is foolishly dismissing as a “.gigantic sideshow.”.While the broader market remains fixated on daily earnings fluctuations and inflation data Cramer urged investors to focus on the structural shift happening in San Francisco.Nvidia and Eli Lilly have cemented

Wed Jan 14, 2026

$1073.29 | -0.36%

Activity

Can Novo Nordisk Unseat Eli Lilly as the Weight Loss Drug Leader in 2026?. Key PointsNovo Nordisk launched an oral version of its best-selling weight management medicine.

Tue Jan 13, 2026

$1077.19 | -0.33%

Activity

Discover LLY Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of LLY. We're here to help you make informed investment decisions today.

FIND US ON

Receive our LLY Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

LLY Stock trends

LLY Stock performance

LLY Stock analysis

LLY investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing LLY

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing LLY

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

LLY Stock Analysis & IQ Rating | Eli Lilly and

LLY Stock IQ

LLY Target Price

LLY Risk Level

LLY Analysts Opinion

LLY Street Sentiment

LLY Performance Sentiment

Technical Price Levels

Explore our LLY Stock insights

Receive our LLY Daily Alerts

LLY Street Sentiment

LLY Risk Level

Technical Price Levels

Discover LLY Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of LLY. We're here to help you make informed investment decisions today.

Receive our LLY Daily Alerts

LLY Alerts